US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Shlomi Raz
Recent news which mentions Shlomi Raz
Psychedelics M&A: Beckley Psytech Acquires Eleusis Therapeutics, Strengthening Drug Pipeline And R&D Team
October 24, 2022
Tags
Beckley Psytech
Market News
News
From
Benzinga
From Finance To Psychology, Shlomi Raz, CEO Of Eleusis: Meet Our Speakers
April 08, 2022
Tickers
GS
JPM
SPKB
Tags
Markets
Small Cap
Psychedelics
From
Benzinga
Psychedelics Firm Eleusis Goes Public Via Merger With Silver Spike Acquisition Creating $450M Company
January 20, 2022
Tickers
SPKB
Tags
Shlomi Raz
Benzinga
psychedelics
From
Benzinga